Zamex is a UK-based veterinary pharmaceutical company, founded in 2020 and headquartered in London. We specialize in
delivering high-quality veterinary solutions across the livestock, poultry, and pet sectors. Our extensive product portfolio includes feed additives, disinfectants, aquaculture products, and specialized formulations for companion animals.
Zamex is dedicated to enhancing animal health and well-being globally. In January 2024, we proudly acquired Daichenberg, further strengthening our market position and broadening our product offerings. Zamex is a VAT-registered company, further ensuring compliance with financial regulations and reinforcing our commitment to transparency and trustworthiness in all our
business dealings.
Our vision is to be a trusted global leader in the veterinary pharmaceutical industry, recognized for our unwavering commitment to quality, innovation, and sustainability.
Our mission is to provide exceptional veterinary pharmaceuticals and solutions that improve animal health and welfare worldwide. We are dedicated to delivering innovative products and outstanding service to meet the evolving needs of our customers in the livestock, poultry, and pet industries.
